Navigation Links
Res-Q Gains Rights To Market Orosine - a Breakthrough, Patented, Natural Heart Supplement That Cardiologists Are Calling the 'Ultimate Cardio Protection' Against Heart Attacks, Strokes and Heart Failure.
Date:12/10/2008

re information, such as case studies on Dr. Shapiro's patients or to hear an audio clip of cardiologists Dr. Shapiro and Dr. Frederic Vagnini discuss Orosine, please go to www.myResQproducts.com.

Dr. Vagnini is a board-certified cardiothoracic surgeon who, after more than 20 years of performing heart surgery, has turned his clinical practice to prevention and nutrition. He is the medical director of two Heart, Diabetes and Longevity Centers in New York City and Long Island, where he sees patients on a daily basis.

Res-Q is a registered trademark of N3 Oceanic, Inc.


'/>"/>
SOURCE N3 Oceanic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

5

GOOD

Page: 1 2

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
3. Despite overeating, morbidly obese mice gain protection against diabetes
4. Alvarado Hospital Files Countersuit Against Blue Shield
5. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
6. Claim Filed Against the Company and Nine Other Defendants in the Haifa Magistrates Court
7. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
8. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
9. $52.5 Million Settlement Against Sepracor Inc. Approved
10. The fight against colorectal cancer
11. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 5DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID 26amp 3B 238482 3B Genetic Test 13611 1DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID 26amp 3B 238482 3B Genetic Test 13611 2DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID 26amp 3B 238482 3B Genetic Test 13611 3Indoor Tanning Association Opposes Suffolk Bill Banning Teens From Sun Beds 54741 1Indoor Tanning Association Opposes Suffolk Bill Banning Teens From Sun Beds 54741 2Union HealthShare Signs Multi Year Multi Million Dollar Agreement with North Star Health 54736 1Union HealthShare Signs Multi Year Multi Million Dollar Agreement with North Star Health 54736 2Union HealthShare Signs Multi Year Multi Million Dollar Agreement with North Star Health 54736 3